NCT05754385View on ClinicalTrials.gov

Ambulatory Liver Fat Monitoring in Patients With Non-alcoholic Fatty Liver Disease

NARecruitingINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

October 31, 2025

Conditions
Non-Alcoholic Fatty Liver Disease
Interventions
BEHAVIORAL

Ambulatory monitoring of liver fat

Participants will be given a novel portable, home-based device called the Gense-EIT liver scan the participants and will practice ambulatory liver fat monitoring for 6 months.

BEHAVIORAL

Standard of care

Subjects will have follow-up every 6 months by hepatologists for routine care

Trial Locations (1)

0000

RECRUITING

The University of Hong Kong, Hong Kong

Sponsors

Collaborators (1)

Gense Technologies Ltd.
All Listed Sponsors
collaborator

Gense Technologies Ltd.

UNKNOWN

lead

The University of Hong Kong

OTHER